LANDOS BIOPHARMA INC (LABP)
US5150692011 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -21.93M | -39.28M | -38.42M | -30.14M | -13.47M | |||
| Depreciation Amortization | 0.00 | 580.00K | 200.00K | 140.00K | 100.00K | |||
| Change In Working Capital | 443.00K | -10.07M | 5.89M | 5.87M | 3.28M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 30.00K | |||
| Other non cash items | 1.01M | 3.00M | 5.27M | 1.17M | 210.00K | |||
| OPERATING CASH FLOW | -20.48M | -45.77M | -27.06M | -22.96M | -9.87M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -10.00K | -440.00K | -180.00K | -160.00K | |||
| Other Investing Activity | 7.78M | 74.07M | -58.27M | 14.31M | -40.17M | |||
| INVESTING CASH FLOW | 7.78M | 74.06M | -58.71M | 14.13M | -40.33M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 7.98M | |||
| Stock Issued/Repurchased | 13.57M | 0.00 | 93.51M | 1.52M | 51.67M | |||
| Other Financing Activity | N/A | 0.00 | -1.91M | N/A | N/A | |||
| FINANCING CASH FLOW | 13.57M | 0.00 | 91.61M | 1.52M | 59.65M | |||
| Exchange Rate Effect | 44.00K | 50.00K | 50.00K | -80.00K | N/A | |||
| CHANGE IN CASH | 909.00K | 28.34M | 5.89M | -7.39M | 9.45M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -20.48M | -45.77M | -27.06M | -22.96M | -9.87M | |||
| Capital Expenditure | 0.00 | -10.00K | -440.00K | -180.00K | -160.00K | |||
| FREE CASH FLOW | -20.48M | -45.78M | -27.50M | -23.14M | -10.03M | |||
All data in USD